Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 2
1973 1
1974 1
1977 2
1978 4
1979 3
1980 3
1981 5
1982 2
1983 7
1984 22
1985 20
1986 22
1987 23
1988 42
1989 39
1990 63
1991 45
1992 40
1993 39
1994 47
1995 31
1996 32
1997 30
1998 38
1999 24
2000 37
2001 32
2002 38
2003 27
2004 24
2005 29
2006 31
2007 41
2008 42
2009 40
2010 51
2011 63
2012 57
2013 89
2014 87
2015 100
2016 123
2017 121
2018 137
2019 131
2020 155
2021 191
2022 160
2023 175
2024 61

Text availability

Article attribute

Article type

Publication date

Search Results

2,410 results

Results by year

Filters applied: . Clear all
Page 1
Nootropics as Cognitive Enhancers: Types, Dosage and Side Effects of Smart Drugs.
Malík M, Tlustoš P. Malík M, et al. Nutrients. 2022 Aug 17;14(16):3367. doi: 10.3390/nu14163367. Nutrients. 2022. PMID: 36014874 Free PMC article. Review.
Based on their nature and their effects, this heterogeneous group of drugs has been divided into four subgroups: classical nootropic compounds, substances increasing brain metabolism, cholinergic, and plants and their extracts with nootropic effects. Each subgroup o …
Based on their nature and their effects, this heterogeneous group of drugs has been divided into four subgroups: classical nootropic …
The Safety and Efficacy of Botanicals with Nootropic Effects.
Roe AL, Venkataraman A. Roe AL, et al. Curr Neuropharmacol. 2021;19(9):1442-1467. doi: 10.2174/1570159X19666210726150432. Curr Neuropharmacol. 2021. PMID: 34315377 Free PMC article. Review.
Recent estimates for the global brain health supplement category, i.e. nootropic market size, will grow to nearly $5.8 billion by 2023. Overall, nearly one-quarter (23%) of adults currently take a supplement to maintain or improve brain health or delay and reverse dementia …
Recent estimates for the global brain health supplement category, i.e. nootropic market size, will grow to nearly $5.8 billion by 202 …
Presence of Piracetam in Cognitive Enhancement Dietary Supplements.
Cohen PA, Zakharevich I, Gerona R. Cohen PA, et al. JAMA Intern Med. 2020 Mar 1;180(3):458-459. doi: 10.1001/jamainternmed.2019.5507. JAMA Intern Med. 2020. PMID: 31764936 Free PMC article.
This study analyzes 5 brands of dietary supplements to determine the prevalence of the nootropic drug piracetam in supplements advertised as cognitive enhancers....
This study analyzes 5 brands of dietary supplements to determine the prevalence of the nootropic drug piracetam in supplements advert …
Neuropharmacological review of the nootropic herb Bacopa monnieri.
Aguiar S, Borowski T. Aguiar S, et al. Rejuvenation Res. 2013 Aug;16(4):313-26. doi: 10.1089/rej.2013.1431. Rejuvenation Res. 2013. PMID: 23772955 Free PMC article. Review.
Several randomized, double-blind, placebo-controlled trials have substantiated BM's nootropic utility in humans. There is also evidence for potential attenuation of dementia, Parkinson's disease, and epilepsy. ...
Several randomized, double-blind, placebo-controlled trials have substantiated BM's nootropic utility in humans. There is also eviden …
Editorial: Smart Drug Delivery Systems (Part 2).
Ficai A. Ficai A. Curr Drug Targets. 2018 Feb 19;19(4):299. doi: 10.2174/138945011904180219114433. Curr Drug Targets. 2018. PMID: 29493448 No abstract available.
Editorial: Smart Drug Delivery Systems (Part 1).
Ficai A. Ficai A. Curr Drug Targets. 2018 Feb 8;19(3):201. doi: 10.2174/138945011903180208165430. Curr Drug Targets. 2018. PMID: 29451108 No abstract available.
Smart Drug Delivery Systems in Cancer Therapy.
Unsoy G, Gunduz U. Unsoy G, et al. Curr Drug Targets. 2018 Feb 8;19(3):202-212. doi: 10.2174/1389450117666160401124624. Curr Drug Targets. 2018. PMID: 27033191 Review.
OBJECTIVE: Advances in drug delivery systems provide reduced side effects, longer circulation half-life and improved pharmacokinetics. RESULTS: Smart drug delivery systems have been achieved successfully in the case of cancer. ...Here, we review targeting, cellular …
OBJECTIVE: Advances in drug delivery systems provide reduced side effects, longer circulation half-life and improved pharmacokinetics. RESUL …
Smart drug delivery systems for precise cancer therapy.
Wang X, Li C, Wang Y, Chen H, Zhang X, Luo C, Zhou W, Li L, Teng L, Yu H, Wang J. Wang X, et al. Acta Pharm Sin B. 2022 Nov;12(11):4098-4121. doi: 10.1016/j.apsb.2022.08.013. Epub 2022 Aug 22. Acta Pharm Sin B. 2022. PMID: 36386470 Free PMC article. Review.
This review summarizes the current progress in various strategies for smart drug delivery systems against malignancies and introduces the representative endogenous and exogenous stimuli-responsive smart delivery systems. ...
This review summarizes the current progress in various strategies for smart drug delivery systems against malignancies and int …
Smart drug delivery systems to overcome drug resistance in cancer immunotherapy.
Yi W, Yan D, Wang D, Li Y. Yi W, et al. Cancer Biol Med. 2023 May 2;20(4):248-67. doi: 10.20892/j.issn.2095-3941.2023.0009. Cancer Biol Med. 2023. PMID: 37144580 Free PMC article. Review.
Furthermore, tumors create an immunosuppressive microenvironment via immunosuppressive cells and secrete molecules that hinder immune cell and immune modulator infiltration or induce immune cell malfunction. To address these challenges, smart drug delivery systems ( …
Furthermore, tumors create an immunosuppressive microenvironment via immunosuppressive cells and secrete molecules that hinder immune cell a …
A randomized, double-blind, placebo controlled, parallel group, efficacy study of alpha BRAIN® administered orally.
Solomon TM, Leech J, deBros GB, Murphy CA, Budson AE, Vassey EA, Solomon PR. Solomon TM, et al. Hum Psychopharmacol. 2016 Mar;31(2):135-43. doi: 10.1002/hup.2520. Epub 2016 Feb 15. Hum Psychopharmacol. 2016. PMID: 26876224 Clinical Trial.
OBJECTIVE: Alpha BRAIN is a nootropic supplement that purports to enhance cognitive functioning in healthy adults. The goal of this study was to investigate the efficacy of this self-described cognitive enhancing nootropic on cognitive functioning in a group of heal …
OBJECTIVE: Alpha BRAIN is a nootropic supplement that purports to enhance cognitive functioning in healthy adults. The goal of this s …
2,410 results